Annotation Detail for COL4A4

Basic Information
Top
Pathway ID | Pathway Name |
---|
| Axon guidance |
| Signaling by PDGF |
| Integrin cell surface interactions |
Pathway ID | Pathway Name |
---|
P00034 | Integrin signalling pathway |
Desease Name |
---|
Alport syndrome, autosomal recessive |
Hematuria, familial benign |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C051890 |
irinotecan |
irinotecan analog results in decreased expression of COL4A4 mRNA | decreases expression | 18927307
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of COL4A4 mRNA | increases expression | 12377990
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.73 | 11752688 14514962 15322242 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
4.26 | 16835633 |
MESH:C536587 |
Alport syndrome, recessive type |
marker/mechanism |
|
| |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.45 | 11748828 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.59 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.86 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
3.05 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.66 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.21 | 16835633 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.60 | 18670907 18850075 16120746 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.63 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.26 | 12621046 8697196 16354765 15340226 15668235 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
2.65 | 17287894 17725105 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
2.37 | 18259882 15273666 17159606 17454858 16391804 16303861 18509181 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.53 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.27 | 15322242 20055451 10048152 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.75 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.63 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
3.12 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.92 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.97 | 16714409 18230668 15322242 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.53 | 9294722 10568697 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.38 | 11564622 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
4.22 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.71 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.66 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.55 | 10048152 11294989 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.89 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.65 | 16120746 15340226 12621046 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
5.12 | 15340226 16959395 8697196 16354765 18606429 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
2.04 | 18670907 18850075 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
2.06 | 12878042 12200463 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.89 | 16580747 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.25 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
1.85 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.38 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
1.24 | 11884234 19555203 |
MESH:D052016 |
Mucositis |
|
irinotecan |
5.89 | 17159606 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.43 | 12213967 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
3.32 | 18259882 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.89 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
3.69 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
5.62 | 8761367 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
5.32 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
4.23 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
4.08 | 11399792 11222880 11118676 11896295 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.51 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.23 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
2.36 | 15723263 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.97 | 12697716 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.66 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
5.32 | 15886252 |